| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | -29.7% | +61.8% |
| Cost of Revenue | $398K | -39.3% | +50.8% |
| R&D Expense | $34.4M | -2.9% | +12.3% |
| SG&A Expense | $19.4M | +44.0% | +67.9% |
| Operating Income | -$51.0M | -16.3% | -26.9% |
| Pre-tax Income | -$71.9M | -92.8% | -61.9% |
| Income Tax | $8.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $597.1M | +135.3% | +137.3% |
| Current Assets | $716.2M | +75.3% | +54.3% |
| Total Assets | $888.4M | +51.9% | +37.6% |
| Current Liabilities | $100.6M | +145.9% | +41.2% |
| Long-term Debt | $51.9M | +0.1% | +1.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$100.4M | — | — |
| Capital Expenditures | $320K | — | — |
| Investing Cash Flow | $119.8M | — | — |
| Financing Cash Flow | $412.9M | — | — |
| Free Cash Flow | -$100.7M | — | — |
| +1929.6% |
| — |
| Net Income | -$80.5M | -113.5% | -81.5% |
| EPS (Basic) | -$1.38 | -100.0% | -51.6% |
| EPS (Diluted) | -$1.38 | -100.0% | -51.6% |
| $659.6M |
| +12.0% |
| +11.8% |
| Stockholders' Equity | $228.7M | +5814.4% | +309.8% |